Literature DB >> 10681316

A sensitive amphotericin B immunoassay for pharmacokinetic and distribution studies.

S Machard1, F Theodoro, H Benech, J M Grognet, E Ezan.   

Abstract

Since currently used assays of amphotericin B (AMB) lack sensitivity or are not easily adaptable in all laboratories, we have developed an enzyme immunoassay for AMB in biological fluids and tissues. Antibodies to AMB were raised in rabbits after administration of an AMB-bovine serum albumin conjugate. The enzymatic tracer was obtained by coupling AMB via its amino group to acetylcholinesterase (EC 3.1.1.7). These reagents were used for the development of a competitive immunoassay performed on microtitration plates. The limit of quantification was 100 pg/ml in plasma and 1 ng/g in tissues. The plasma assay was performed directly without extraction on a minimal volume of 0.1 ml. The intra- and interassay coefficients of variation were in the range of 5 to 17%, and the recoveries were 92 to 111% for AMB added to human plasma. The assay was applied to a pharmacokinetic study with mice given AMB intraperitoneally at the dose of 1 mg/kg. The drug distribution in selected compartments (plasma, liver, spleen, lung, and brain) was monitored until 72 h after administration. In conclusion, our assay is at least 100-fold more sensitive than previously described bioassays or chromatographic determinations of AMB and may be useful in studying the tissue pharmacokinetics of new AMB formulations and in drug monitoring in clinical situations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10681316      PMCID: PMC89724          DOI: 10.1128/AAC.44.3.546-550.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

Review 1.  Is there a therapeutic or pharmacokinetic rationale for amphotericin B dosing in systemic Candida infections?

Authors:  M P Nagata; C A Gentry; E M Hampton
Journal:  Ann Pharmacother       Date:  1996 Jul-Aug       Impact factor: 3.154

Review 2.  Amphotericin B: new life for an old drug.

Authors:  S Hartsel; J Bolard
Journal:  Trends Pharmacol Sci       Date:  1996-12       Impact factor: 14.819

3.  Rapid high performance liquid chromatographic assay for antifungal agents in human sera.

Authors:  T K Ng; R C Chan; F A Adeyemi-Doro; S W Cheung; A F Cheng
Journal:  J Antimicrob Chemother       Date:  1996-03       Impact factor: 5.790

Review 4.  Probing the dynamics of prion diseases with amphotericin B.

Authors:  K T Adjou; J P Deslys; R Demaimay; D Dormont
Journal:  Trends Microbiol       Date:  1997-01       Impact factor: 17.079

5.  New high-performance liquid chromatographic method for amphotericin B analysis using an internal standard.

Authors:  M P Lambros; S A Abbas; D W Bourne
Journal:  J Chromatogr B Biomed Appl       Date:  1996-10-11

6.  Serum pharmacology of amphotericin B applied in lipid emulsions.

Authors:  V Heinemann; B Kähny; U Jehn; D Mühlbayer; A Debus; K Wachholz; D Bosse; H J Kolb; W Wilmanns
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

7.  Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits.

Authors:  J W Lee; M A Amantea; P A Francis; E E Navarro; J Bacher; P A Pizzo; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

8.  Amphotericin B enzyme-linked immunosorbent assay.

Authors:  J D Cleary; S W Chapman; J Deng; C J Lobb
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

9.  Determination of amphotericin B in human serum by liquid chromatography.

Authors:  R Lopez-Galera; L Pou-Clave; C Pascual-Mostaza
Journal:  J Chromatogr B Biomed Appl       Date:  1995-12-15

10.  Activity of liposomal amphotericin B (AmBisome) against Leishmania infantum and tissue distribution in mice.

Authors:  L Gradoni; R N Davidson; S Orsini; P Betto; M Giambenedetti
Journal:  J Drug Target       Date:  1993       Impact factor: 5.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.